Introduction: Maternal diabetes has been recognised for adverse maternal and perinatal outcomes. Aims of this study were to the mode of delivery, maternal morbidity, neonatal morbidity and mortality in pregnant diabetes (DM) women with normal pregnant women.
INTRODUCTION
Diagnosing and treating GDM will prevent maternal, perinatal and long term complications to both mother and the offspring 3 . High prevalence of type II DM and GDM in Sri Lankan 4 women of South Asian origin makes them susceptible to adverse effects of hyperglycaemia if remained undiagnosed during pregnancy. Maternal hyperglycaemia in early pregnancy increases the risk of birth defects and miscarriage in type I or II diabetes 5 . In Gestational diabetes hyperglycaemia occurs in the second half of the pregnancy, increase the risks of accelerated foetal growth, late stillbirth, birth trauma and neonatal hypoglycaemia 6 . The risk of late unexpected stillbirth among women with diabetes is approximately fourfold higher when untreated compared to non-diabetic population after 40 weeks of period of amenorrhoea 7 .
Diabetic women are at increased risk of pregnancy induced hypertension and preeclampsia 8 . Women who had been diabetic for years before pregnancy are at higher risk of micro vascular disease such as hypertension, nephropathy and retinopathy
9
. Micro albuminuria or proteinuria indicates renal micro vascular involvement with increased risk of placental insufficiency, pre eclampsia and preterm delivery 3 .
This study was designed to compare the maternal and neonatal outcomes (during the hospital stay) of women with diabetes and non-diabetes in pregnancy among urban women in Sri Lanka. 
MATERIALS AND METHODS

STATISTICAL ANALYSIS
Phenotypic data were directly entered into an electronic database and manually verified for errors. In the analysis, summary values are presented as the mean [standard deviation (SD)] when data were normally distributed, and as the median (inter quartile range) when not distributed normally. Student's t-test was used to test for differences between groups where the data were normally distributed. Chi square test and Fisher's exact test were used to compare frequencies and proportions when categorical data are presented as percentage distributions. P value <0.05 was taken as the level of significance.
RESULTS
Total number of deliveries during the six months study period was 1264. Total sample size 270 women with 135 diabetic women and 135 parity matched normal pregnant women. There were 15 women previously diagnosed as type II DM and 120 diagnosed as GDM during pregnancy. The percentage of DM in pregnancy in this study was 10.6%. Percentage of GDM was 9.4% and pre-pregnancy DM was 1.2%.
Polyhydramnios at term was the commonest maternal complication in pregnancy in the DM women with 16 (11.8%) women and only four (2.9%) in the control group (p<0.01). Pregnancy induced hypertension without protein urea was the second frequent complication in eleven (8%) of DM women (p=0.02) compared to the controls having only three (2.2%). Other antenatal maternal complications were preterm labour (3 in DM versus none in the controls), hypothyroidism (2 in DM versus one in the controls) and anaemia (one in the DM versus two in the controls) with no statistical difference in both groups. Oligohydramnios was detected in four women in the DM group versus six women in the control group (p=0.3).
There were 16 (11.8%) women with high Fasting (>110mg/dl) or 2hour postprandial blood glucose (>140mg/ dl) in the GDM group 48 hours after delivery. Primary postpartum haemorrhage was the commonest postpartum complication found in the control group with four women and only one in the DM group (p=0.1).
Comparison of mean, standard deviation of birth weight and the period of amenorrhoea at delivery is given in table 1. Comparison of onset of labour and induction of labour, mode of delivery in the two groups and neonatal out comes are given in table 2, 3, 4 respectively. Shoulder dystocia was not encountered in this study population.
Descriptive data of seven neonates admitted to neonatal unit in the DM group and neonatal unit admissions of seven neonates in the control group are given in table 5 and 6 respectively. The duration of stay in the neonatal unit was similar in both groups, with a mean of 3 days and the range 1-5 days (when the 29 week extreme premature neonate was excluded in the DM group). There were only two birth defects in the whole study group with a cleft palate and a cystic hygroma in neonates of GDM mothers.
DISCUSSION
Diabetes in pregnancy has adverse maternal and perinatal outcomes compared to normal pregnancy
10
. This study found that in women with DM in pregnancy had a significantly higher frequency of polyhydramnios and pregnancy induced hypertension compared to controls. Polyhydramnios was defined as amniotic fluid index of 20cm or more. This is a common complication in GDM women when glycaemic Original PaPer www.slcog.lk/sljog control is sub optimal. However there was no increase perinatal morbidity or mortality in these women. Although pregnancy induced hypertension was significantly higher in the DM group this was not associated with pre eclampsia. The presence of type II DM was 1.2% and none of these women had micro vascular disease detected during the current pregnancy, the duration of disease ranged from 0.5 years to 7 years prior to present pregnancy.
The mean delivery POA in the DM group was 37 weeks and two days (SD=1.2), this was significantly low compared to the 38 weeks and four days (SD=3.4) in the controls (table  1) . This difference can be attributed to the higher rate of induction of labour in the DM group 43% compared to 16% in controls (table 2) . Also the significantly high elective caesarean rate (44%) in the DM group compared to 31% in the controls too may contribute to the lower mean POA at delivery in the DM (table 3) . No significant different of the mean BWs were found, the lower mean POA at delivery of DM mothers may have been a contributory factor (table 1) .
Neonatal complications such as macrosomia (BW ≥3.5Kg), prematurity, intra uterine growth restriction, still births and neonatal deaths were not statistically different in DM compared with controls (table  4) . These findings could be attributed to the good treatment compliance of the DM mothers, an optimal glycaemic control during the pregnancy and timely delivery. Although there was no statistical significant increase of prematurity in the DM group of the five premature infants needing intensive care admissions, only two had preterm labour, two emergency sections for pre eclampsia and fetal distress, the other was an elective delivery (table  5) . The elective delivery of DM with a normal glycaemic control should be delayed up to 39 completed weeks as evidence show respiratory morbidity in neonates, requiring admission to the neonatal intensive care is more if delivered early by elective caesarean section 11 .
Hypoglycaemia (plasma glucose ≤50mg/dl) a known complication of neonates of DM mothers was significantly higher in DM group compared to controls with in the first 24hours of delivery (table 4) . Neonatal hypoglycaemia is a consequence of persistent fetal hyper-insulinaemia occurring after birth when the maternal transfer of glucose has ceased. This study also found neonatal pyrexia to be significantly higher in the DM group compared to controls (table 4) .
Sixteen (11%) women had high fasting and post prandial blood glucose 48 hours after delivery; they were not previously known type II DM. Majority of the GDM women will subsequently become type II DM
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. Life style changes to minimize weight gain with physical activity and diet had shown to slow the progression to type II DM in these women 12 .
Maternal diabetes with suboptimal glycaemic control can influence aspects of fetal metabolic programming and an increased risk of type 2 diabetes in adult life 13 . Therefore diagnosing DM and optimal glycaemic control during pregnancy will minimise the short term and long term complications to the offspring of DM mothers. 
